Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Prepaid Assets: 2017-2025

Historic Prepaid Assets for Cidara Therapeutics (CDTX) over the last 8 years, with Sep 2025 value amounting to $14.6 million.

  • Cidara Therapeutics' Prepaid Assets fell 47.26% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year decrease of 47.26%. This contributed to the annual value of $12.9 million for FY2024, which is 651.52% up from last year.
  • Per Cidara Therapeutics' latest filing, its Prepaid Assets stood at $14.6 million for Q3 2025, which was up 12.16% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Cidara Therapeutics' Prepaid Assets ranged from a high of $27.7 million in Q3 2024 and a low of $1.7 million during Q4 2023.
  • Over the past 3 years, Cidara Therapeutics' median Prepaid Assets value was $5.7 million (recorded in 2023), while the average stood at $9.2 million.
  • Per our database at Business Quant, Cidara Therapeutics' Prepaid Assets tumbled by 73.78% in 2023 and then spiked by 651.52% in 2024.
  • Cidara Therapeutics' Prepaid Assets (Quarterly) stood at $4.1 million in 2021, then surged by 60.48% to $6.5 million in 2022, then tumbled by 73.78% to $1.7 million in 2023, then surged by 651.52% to $12.9 million in 2024, then slumped by 47.26% to $14.6 million in 2025.
  • Its Prepaid Assets stands at $14.6 million for Q3 2025, versus $13.0 million for Q2 2025 and $12.7 million for Q1 2025.